Please assess the completion status of the following clinical trial:

Trial Title: Evaluation and Longitudinal Follow-up of Biomarkers Predictive of Severe Forms of COVID-19

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Social security affiliation~* Signed informed consent~* Patients with COVID infection documented by PCR and/or antigenic testing~* Patients belonging to the following groups:~  * asymptomatic patients with PCR-positive PCR~ * patients with mild symptoms and PCR positive~ * seriously symptomatic patients with PCR positive~ * patients in resuscitation with positive PCR~ * Healthy individuals as controls~Exclusion Criteria:~* haemoglobin \< 8g/dL~* Pregnancy, breastfeeding woman~* Patient vaccinated within 15 days prior to inclusion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: None

Study Arms:
- asymptomatic patients (Type: None): asymptomatic patients with PCR-positive PCR
- mild symptoms patients (Type: None): patients with mild symptoms and PCR positive
- seriously symptomatic patients (Type: None): seriously symptomatic patients with PCR positive
- patients in resuscitation (Type: None): patients in resuscitation with positive PCR
- heathly volunteer (Type: None): heathly volunteer as control

Based on this trial design, predict the completion outcome and termination type (if applicable).